Antifungal Susceptibility Testing

Clinical Microbiology Newsletter

Volumn 18, Issue 21, 1996, Pages 161-167

  Espinel Ingroff, Ana ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007052695     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-4399(96)88204-3     Document Type: Article

References (30)

1. Espinel-Ingroff, A. 1996. Standardization of antifungal susceptibility testing: Update review. Rev. Iberoam. Mycol. In press.
2. Beck-Sague, C.M., W.R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
3. Wingard, J.R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.
4. Hazen, K.C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
5. Vartivarian, S.E., E.J. Anaissie, and G.P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 17:S487-S491.
6. Powderly, W.G. 1992. Therapy for cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. (Suppl. 1) 14:S54-S59.
7. Galgiani, J.N., et al. 1993. Fluconazole therapy for coccidioidal meningitis. Ann. Intern. Med. 119:28-35.
8. Dismukes, W.E., et al. 1992. Itraconazole therapy for blastomycosis and histoplasmosis. Am. J. Med. 93:489-497.
9. Graybill, J.R., et al. 1990. Itraconazole treatment of coccidioidomycosis. Am. J. Med. 89:282-290.
10. Denning, D.W., et al. 1994. MAID mycoses study group multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am. J. Med. 97:135-144.
11. Sharkey-Mathis, P.K., et al. 1993. Treatment of sporotrichosis with itraconazole. Am. J. Med. 95:279-285.
12. Rex, J.H., M.G. Rinaldi, and M.A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
13. Galgiani, J.N., et al. 1987. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob. Agents Chemother. 31:1343-1347.
14. Espinel-Ingroff, A., et al. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
15. Fromtling, R.A., et al. 1993. Multicenter evaluation of a macrobroth antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
16. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution susceptibility testing of yeasts; Proposed Standard. NCCLS document M27-P (ISBN 1-56238-186-5). NCCLS, 771 E. Lancaster Avenue, Villanova, Pennsylvania 19085.
17. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts; Tentative standard. NCCLS document M27-T. NCCLS, 771 E. Lancaster Avenue, Villanova, Pennsylvania 19085.
18. Espinel-Ingroff, A. and M. Pfaller. 1995. Antifungal agents and susceptibility testing, p. 1405-1421. In P.K. Murray, E.J. Baron, M.A. Pfaller, et al. (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology. Washington, D.C.
19. Pfaller, M.A., et al. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards - recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J. Clin. Microbiol. 33:1104-1107.
20. 19a. Rex, J.H., et al. 1996. Quality control guidelines for National Committee for Clinical Laboratory Standards - recommended broth macrodilution testing of ketoconazole and itraconazole. J. Clin. Microbiol. 34:816-817.
21. Pfaller, M.A. et al. 1994. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J. Clin. Microbiol. 32:506-509.
22. Anaissie, E, V. Paetznick, and G.P. Bodey. 1991. Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum, size, temperature, and time of reading. Antimicrob. Agents Chemother. 35:1641-1646.
23. Pfaller, M.A., S.A. Messer, and S. Coffmann. 1995. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution method to test five antifungal agents including the new triazole D0870. J. Clin. Microbiol. 33:1094-1097.
24. Espinel-Ingroff, A., J.L. Rodríguez-Tudela, and J.V. Martínez-Suárez. 1995. Comparison of two microdilution methods with the reference macrodilution test M27-P for in vitro testing of fluconazole resistant and susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
25. Espinel-Ingroff, A. 1994. Etest for antifungal susceptibility testing of yeasts. Diagn. Microbiol. Infect. Dis. 19:217-220.
26. Colombo, A.L., et al. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole susceptibility testing. J. Clin. Microbiol. 33:535-540.
27. Espinel-Ingroff, A. et al. 1996. Interlaboratory evaluation of Etest method for antifungal susceptibility testing of pathogenic yeasts to five antifungal agents by using casitone agar and solidified RPMI-1640 medium with 2% glucose. J. Clin. Microbiol. 34:848-852.
28. Espinel-Ingroff, A. et al. 1995. Comparative and collaborative evaluation of standardization antifungal susceptibility testing for filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
29. Espinel-Ingroff, A., et al. 1995. Second NCCLS evaluation of antifungal susceptibility testing of filamentous fungi. 35th Intersci. Conf. Antimicrob. Agents Chemother. (Abstr. D37), p. 73.
30. Rex, J., et al. 1996. Development of interpretative breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Submitted.